Clinical Trial Update: A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pembrolizumab with azacitidine in chemo-refractory metastatic colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Anuradha Krishnamurthy | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-16